Hepatitis C virus antibody (anti-HCV): Prevalence in psoriasis

International Journal of Dermatology

Volumn 35, Issue 11, 1996, Pages 797-799

  Chouela, Edgardo ^a   Abeldaño, Alejandra ^b   Panetta, Josefina ^b   Ducard, Mariana ^b   Neglia, Vincenta ^b   Sookoian, Silvia ^b   Kina, Mirta ^b   Castaño, Gustavo ^b   Vereytou, Fernando ^b   Frider, Bernardo ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PSORIASIS; SCHOOL CHILD;

EID: 10544242534     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4362.1996.tb02977.x     Document Type: Article

References (26)

1. Jones S, Aneine W, Campbell M, White J. Methotrexate pharmacokinetics in psoriatic patients developing hepatic fibrosis. Arch Dermatol 1986; 122:666-669.
2. O'Connor GT, Olmstead EM, Bangmman RD, et al. Detection of hepatotoxicity associated with methotrexate therapy for psoriasis. Arch Dermatol 1989; 125: 1209-1217.
3. Whitin G, O'Keefe QE, Fye KM, Sack KD. Methotrexate and histologic hepatic abnormalities: a metaanalysis. Am J Med 1991; 90:711-716.
4. Guadagnino V, Avala F, Chirianni A, et al. Risk of hepatitic B virus infection in patients with eczema or psoriasis of the hand. BMJ 1982; 284:84.
5. Choo KL, Kuo G, Weiner AJ, et al. Isolation of cDNA clone derived from blood-borne non A-non B viral hepatitis genome. Science 1989; 244:359-362.
6. Alter HJ. Descartes before de horse. I clone therefore I am: the hepatitis C virus in current perspective. Ann Intern Med 1991; 115:644-649.
7. Reeves WH. Autoimmune mechanism in psoriasis. Semin Dermatol 1991; 10:217-224.
8. McFadden J, Valdimarsson H, Fry L. Cross-reactivity between streptococcal M surface antigen and human skin. Br J Dermatol 1991; 125:443-447.
9. Martin P. Hepatitis C: more than just a liver disease. Gastroenterology 1993; 104:320-323. [Editorial]
10. Pateron D, Hartmann DJ, Duclose-Valle JC, et al. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J Hepatol 1992; 244-245. (Letter)
11. Haddad J, Deny P, Munoz-Gotheil C, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C liver disease. Lancet 1992; 339: 321-323.
12. Agnelo V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in Type II cryoglobulinemia. N Engl J Med 1992; 327:1490-1495.
13. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). Lichen planus and liver diseases: a multicentre case-control study. BMJ 1990; 300:227-230.
14. Pawlotsky JM, Jubert K, Bagot M, et al. Lichen planus: a novel hepatitis C virus-related disease (Report of 5 cases). J Hepatol 1992; 16(Suppl 1):S108,T161.
15. Giavino G, Sookoian S, Kien M, et al. Liquen plano folicular y hepatitis. XV. Reunión Dermatólogos Latinoamericanos del Cono Sur. Proc May 1993.
16. Fargion S, Piperno A, Cappellini MD, et al. Hepatitis C virus and prophyria cutanea tarda: evidence of a strong association. Hepatology 1992; 16:1322-1326.
17. DeCastro M, Sanchez J, Herrera JF, et al. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 1993; 17:551-557.
18. Herrero C, Vicente A, Bruguera M, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993; 341:788-789.
19. Patoux-Piboulin M, Le Gall F, Jouanolle H, et al. Der-mohypodermite subintrante associée à une hépatite chronique active due au virus C. Ann Dermatol Venereol 1991; 118:854-855.
20. Telfer NR, Chalmers RJC, Whale K, Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 1992; 128:39-42.
21. Findor J, Frider B, Bruch E, et al. Prevalence of anti-hepatitis C virus (HCV) by second generation enzymoimmunoassay, (FJA) in hemodialysis units. Confirmation by line-immunoassay (Liatek). Proceedings of International Symposium on viral hepatitis and liver diseases. Tokyo, Japan 1993:568:228.
22. Choc B, Manterola AC, Diaz Lestrem M, et al. Prevalence of antibody to hepatitis B core antigen (anti-HBc) in Buenos Aires hospital personnel. Bol Of Sanit Panam 1990; 108:16-26.
23. Bradley DW, Maynard JE, Popper H, et al. Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents. J Infect Dis 1983; 141:254-265.
24. Alter MJ, Hadler SC, Judson FN, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264:2231-2235.
25. Alberti A, Chemello L, Cavalleto D, et al. Antibody to hepatitis C virus and liver disease in volunteer blood donors. Ann Intern Med 1991; 114:1010-1012.
26. Esteban JI, Lopez-Talavera JC, Genesca AJ, et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991; 115:443-449.